Randomized, Multicentre, Phase III Study: Assessment of the Duration of Androgen Blockade Combined With Pelvic Irradiation in High-Risk Prostate Cancers.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 May 2017
At a glance
- Drugs Bicalutamide (Primary) ; Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 09 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 09 May 2017 Planned primary completion date changed from 1 Jan 2016 to 1 Dec 2017.
- 18 Jul 2013 Planned End Date added (Dec 2016) as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History